InvestorsObserver
×
News Home

What is the Market's View on Vir Biotechnology Inc (VIR) Stock's Price and Volume Trends Monday?

Monday, June 14, 2021 02:14 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Vir Biotechnology Inc (VIR) Stock's Price and Volume Trends Monday?

Overall market sentiment has been down on Vir Biotechnology Inc (VIR) stock lately. VIR receives a Bearish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Vir Biotechnology Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VIR!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.

Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With VIR Stock Today?

Vir Biotechnology Inc (VIR) stock is up 2.13% while the S&P 500 has fallen -0.27% as of 2:09 PM on Monday, Jun 14. VIR has risen $0.97 from the previous closing price of $45.53 on volume of 350,405 shares. Over the past year the S&P 500 has risen 38.13% while VIR has risen 30.51%. VIR lost -$3.10 per share in the over the last 12 months.

To see InvestorsObserver's Sentiment Score for Vir Biotechnology Inc click here.

More About Vir Biotechnology Inc

Vir Biotechnology Inc is a clinical-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions.

Click Here to get the full Stock Score Report on Vir Biotechnology Inc (VIR) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App